Match!

Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer

Published on Aug 1, 2019in Cancer Epidemiology2.62
· DOI :10.1016/j.canep.2019.05.010
Clare Pearson1
Estimated H-index: 1
(PHE: Public Health England),
Jess Fraser1
Estimated H-index: 1
(PHE: Public Health England)
+ 8 AuthorsJon Shelton2
Estimated H-index: 2
View in Source
Abstract
Abstract Background Diagnostic timeliness in cancer patients is important for clinical outcomes and patient satisfaction but, to-date, continuous monitoring of diagnostic intervals in nationwide incident cohorts has been impossible in England. Methods We developed a new methodology for measuring the secondary care diagnostic interval (SCDI - first relevant secondary care contact to diagnosis) using linked cancer registration and healthcare utilisation data. Using this method, we subsequently examined diagnostic timeliness in colorectal and lung cancer patients (2014–15) by socio-demographic characteristics, diagnostic route and stage at diagnosis. Results The approach assigned SCDIs to 94.4% of all incident colorectal cancer cases [median length (90th centile) of 25 (104) days] and 95.3% of lung cancer cases [36 (144) days]. Advanced stage patients had shorter intervals (median, colorectal: stage 1 vs 4 - 34 vs 19 days; lung stage 1&2 vs 3B&4 - 70 vs 27 days). Routinely referred patients had the longest (colorectal: 61, lung: 69 days) and emergency presenters the shortest intervals (colorectal: 3, lung: 14 days). Comorbidities and additional diagnostic tests were also associated with longer intervals. Conclusion This new method can enable repeatable nationwide measurement of cancer diagnostic timeliness in England and identifies actionable variation to inform early diagnosis interventions and target future research.
  • References (20)
  • Citations (1)
References20
Newest
#1Ruth Swann (PHE: Public Health England)H-Index: 9
#2Sean McPhail (PHE: Public Health England)H-Index: 12
Last.Greg Rubin (Newcastle University)H-Index: 28
view all 9 authors...
22 CitationsSource
#1Peter Murchie (Aberd.: University of Aberdeen)H-Index: 21
#2Sarah Smith (Aberd.: University of Aberdeen)H-Index: 8
Last.Shona Fielding (Aberd.: University of Aberdeen)H-Index: 19
view all 7 authors...
15 CitationsSource
#1Camille Maringe (Lond: University of London)H-Index: 14
#2Helen Fowler (Lond: University of London)H-Index: 4
Last.Miguel Angel Luque-Fernandez (Lond: University of London)H-Index: 10
view all 4 authors...
19 CitationsSource
#1Silvia C Mendonca (University of Cambridge)H-Index: 7
#2Gary A. Abel (University of Cambridge)H-Index: 30
Last.Georgios Lyratzopoulos (University of Cambridge)H-Index: 35
view all 5 authors...
22 CitationsSource
#1Paul Cane (Guy's and St Thomas' NHS Foundation Trust)H-Index: 11
#2Karen M. Linklater (PHE: Public Health England)H-Index: 22
Last.Michael D Peake (Glenfield Hospital)H-Index: 15
view all 5 authors...
2 CitationsSource
#1Pramit A. Nadpara (VCU: Virginia Commonwealth University)H-Index: 5
#2Suresh Madhavan (WVU: West Virginia University)H-Index: 22
Last.Cindy Tworek (WVU: West Virginia University)H-Index: 17
view all 3 authors...
27 CitationsSource
#1Henry Jensen (AU: Aarhus University)H-Index: 8
#2Marie Louise Tørring (AU: Aarhus University)H-Index: 12
Last.Peter Vedsted (AU: Aarhus University)H-Index: 38
view all 6 authors...
32 CitationsSource
#1Richard D Neal (Bangor University)H-Index: 36
#2Puvan Tharmanathan (Ebor: University of York)H-Index: 9
Last.Jon Emery (University of Melbourne)H-Index: 42
view all 20 authors...
197 CitationsSource
#1Georgios Lyratzopoulos (University of Cambridge)H-Index: 35
#2Catherine L. Saunders (University of Cambridge)H-Index: 10
Last.Greg Rubin (Durham University)H-Index: 28
view all 7 authors...
53 CitationsSource
#1Sean McPhail (PHE: Public Health England)H-Index: 12
#2S Johnson (PHE: Public Health England)H-Index: 3
Last.Brian Rous (PHE: Public Health England)H-Index: 2
view all 5 authors...
73 CitationsSource
Cited By1
Newest
#1David Oliver (Berkshire Hathaway)H-Index: 4
2 CitationsSource
View next paperTimeliness of cancer care from diagnosis to treatment: a comparison between patients with breast, colon, rectal or lung cancer